Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806825) titled 'Evaluation of the Acceptability, Feasibility and Exploration of the Efficacy of an Integrated Care Pathway CARIBOU' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
Primary Sponsor: Universidad de los Andes, Chile
Condition:
Major Depressive Disorder (MDD)
Intervention:
Behavioral: CARIBOU Integrated Care Pathway
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: July 1, 2027
Target Sample Size: 72
Countries of Recruitment:
Chile
To know more...